For Pharmacy

Vial Cost

Acquisition cost should be evaluated alongside dosing, redosing, and overall utilization.

Per-kilogram dosing affects total volume, preparation, and drug usage.

Redosing frequency can influence total cost, workflow, and patient exposure.

Speed of FiO₂ reduction may impact respiratory management decisions.

Formulation characteristics affect delivery efficiency and ease of administration.

Delivery time impacts nursing and respiratory therapy workflow.

Rates of delivery-related complications inform safety assessments.

Reflux may reduce effective dose delivery and clinical response.

Overall safety profile supports formulary and protocol decisions.

Impact on ventilation and oxygen days may affect resource utilization.

Compatibility with less invasive approaches supports evolving NICU practices.

Total cost of care extends beyond acquisition price alone.

Surfactant choice should support institutional care pathways.

Storage, handling, and preparation affect pharmacy operations.

Depth and quality of evidence support informed selection.